Evolent Health Inc
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated platform for health plan administration and value-based business infrastructure. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, anal… Read more
Evolent Health Inc (EVH) - Net Assets
Latest net assets as of September 2025: $842.23 Million USD
Based on the latest financial reports, Evolent Health Inc (EVH) has net assets worth $842.23 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.45 Billion) and total liabilities ($1.61 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $842.23 Million |
| % of Total Assets | 34.33% |
| Annual Growth Rate | 55.01% |
| 5-Year Change | 61.6% |
| 10-Year Change | 7.13% |
| Growth Volatility | 149.53 |
Evolent Health Inc - Net Assets Trend (2012–2024)
This chart illustrates how Evolent Health Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Evolent Health Inc (2012–2024)
The table below shows the annual net assets of Evolent Health Inc from 2012 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $1.00 Billion | -6.22% |
| 2023-12-31 | $1.07 Billion | +24.24% |
| 2022-12-31 | $859.42 Million | +23.90% |
| 2021-12-31 | $693.63 Million | +11.95% |
| 2020-12-31 | $619.60 Million | -33.31% |
| 2019-12-31 | $929.05 Million | -21.89% |
| 2018-12-31 | $1.19 Billion | +13.67% |
| 2017-12-31 | $1.05 Billion | +14.71% |
| 2016-12-31 | $912.11 Million | -2.40% |
| 2015-12-31 | $934.58 Million | +45248.74% |
| 2014-12-31 | $-2.07 Million | -106.67% |
| 2013-12-31 | $31.04 Million | +496.89% |
| 2012-12-31 | $5.20 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Evolent Health Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 76023400000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $1.17 Million | 0.12% |
| Other Comprehensive Income | $-1.75 Million | -0.18% |
| Other Components | $1.78 Billion | 178.04% |
| Total Equity | $1.00 Billion | 100.00% |
Evolent Health Inc Competitors by Market Cap
The table below lists competitors of Evolent Health Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Tredegar Corporation
NYSE:TG
|
$231.12 Million |
|
Appen Ltd
AU:APX
|
$231.12 Million |
|
Hangzhou Biotest Biotech Co Ltd
SHG:688767
|
$231.15 Million |
|
ToolGen Inc.
KQ:199800
|
$231.16 Million |
|
Jiusheng Electric Co. LTD
SHE:301082
|
$231.05 Million |
|
Hyliion Holdings Corp.
NYSE MKT:HYLN
|
$230.99 Million |
|
Lanzhou Foci Pharmaceutical Co Ltd
SHE:002644
|
$230.91 Million |
|
Logo Yazilim Sanayi ve Ticaret AS
IS:LOGO
|
$230.85 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Evolent Health Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,067,701,000 to 1,001,259,000, a change of -66,442,000 (-6.2%).
- Net loss of 61,623,000 reduced equity.
- Dividend payments of 20,085,000 reduced retained earnings.
- Share repurchases of 16,624,000 reduced equity.
- Other comprehensive income decreased equity by 496,000.
- Other factors increased equity by 32,386,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-61.62 Million | -6.15% |
| Dividends Paid | $20.09 Million | -2.01% |
| Share Repurchases | $16.62 Million | -1.66% |
| Other Comprehensive Income | $-496.00K | -0.05% |
| Other Changes | $32.39 Million | +3.23% |
| Total Change | $- | -6.22% |
Book Value vs Market Value Analysis
This analysis compares Evolent Health Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.31x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 19.62x to 0.31x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | $0.14 | $2.67 | x |
| 2013-12-31 | $0.81 | $2.67 | x |
| 2014-12-31 | $-0.05 | $2.67 | x |
| 2015-12-31 | $14.07 | $2.67 | x |
| 2016-12-31 | $15.60 | $2.67 | x |
| 2017-12-31 | $15.71 | $2.67 | x |
| 2018-12-31 | $14.79 | $2.67 | x |
| 2019-12-31 | $11.20 | $2.67 | x |
| 2020-12-31 | $7.30 | $2.67 | x |
| 2021-12-31 | $8.06 | $2.67 | x |
| 2022-12-31 | $9.17 | $2.67 | x |
| 2023-12-31 | $9.60 | $2.67 | x |
| 2024-12-31 | $8.73 | $2.67 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Evolent Health Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -6.15%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2.41%
- • Asset Turnover: 1.00x
- • Equity Multiplier: 2.54x
- Recent ROE (-6.15%) is above the historical average (-30.70%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -370.37% | -230.81% | 0.51x | 3.13x | $-19.78 Million |
| 2013 | 64.50% | 78.00% | 0.25x | 3.28x | $16.92 Million |
| 2014 | 0.00% | -25.02% | 2.64x | 0.00x | $-25.04 Million |
| 2015 | 51.20% | 343.21% | 0.10x | 1.56x | $267.56 Million |
| 2016 | -22.74% | -62.84% | 0.21x | 1.71x | $-229.99 Million |
| 2017 | -6.00% | -13.95% | 0.33x | 1.30x | $-161.75 Million |
| 2018 | -4.60% | -8.40% | 0.36x | 1.51x | $-167.04 Million |
| 2019 | -32.74% | -43.95% | 0.46x | 1.62x | $-394.21 Million |
| 2020 | -53.95% | -36.15% | 0.63x | 2.38x | $-396.21 Million |
| 2021 | -5.42% | -4.14% | 0.64x | 2.05x | $-106.96 Million |
| 2022 | -2.23% | -1.42% | 0.74x | 2.11x | $-105.11 Million |
| 2023 | -10.59% | -5.76% | 0.73x | 2.51x | $-219.81 Million |
| 2024 | -6.15% | -2.41% | 1.00x | 2.54x | $-161.75 Million |
Industry Comparison
This section compares Evolent Health Inc's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $171,670,176
- Average return on equity (ROE) among peers: -102.33%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Evolent Health Inc (EVH) | $842.23 Million | -370.37% | 1.91x | $231.08 Million |
| Accolade, Inc. (ACCD) | $390.85 Million | -12.96% | 0.22x | $448.32 Million |
| Achiko AG (ACHKF) | $-625.49K | 0.00% | 0.00x | $314.42K |
| Ascom Holding AG (ACMLF) | $71.10 Million | 9.14% | 1.86x | $152.13 Million |
| Accelera Innovations Inc (ACNV) | $-6.40 Million | 0.00% | 0.00x | $5.72K |
| Aclarion Inc (ACON) | $970.06K | -720.88% | 1.19x | $1.93 Million |
| Alternate Health Corp (AHGIF) | $-13.82K | 0.00% | 0.00x | $6.50K |
| AI/ML Innovations Inc (AIMLF) | $-1.77 Million | 0.00% | 0.00x | $6.84 Million |
| NetraMark Holdings Inc. (AINMF) | $1.83 Million | -284.61% | 0.19x | $70.13 Million |
| AMJ Global Technology (AMJT) | $-118.08K | 0.00% | 0.00x | $10.99 Million |
| American Well Corp (AMWL) | $1.26 Billion | -13.99% | 0.15x | $78.48 Million |